Skip to main content

Want a detailed portfolio tracker?

Moderna (MRNA) P/E (2018 - 2026)

Moderna (MRNA) P/E from Dec 31, 2018 to Jul 21, 2026. The TTM Moderna (MRNA) P/E is -7.35. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Moderna (MRNA)

YearP/EChange
2026-7.35+80.51%
2025-4.07-9.20%
2024-4.49-58.77%
2023-10.88-278.86%
20226.08-27.53%
20218.40-115.32%
2020-54.81+334.04%
2019-12.63-64.43%
2018-35.50N/A

Comparison Moderna (MRNA) P/E with competitors

Moderna (MRNA) P/E is -7.35.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.06%
ENLVEnlivex Ltd0.07-101.02%
FGENFibroGen Inc0.24-103.26%
CHRSCoherus Biosciences Inc0.85-111.54%
FBIOFortress Biotech Inc0.95-112.90%
ORMPOramed Pharmaceuticals Inc1.50-120.44%
AGENAgenus Inc3.01-140.92%
INVAInnoviva Inc3.15-142.88%
VXRTVaxart Inc3.55-148.26%
CRMDCorMedix Inc3.63-149.33%
CVACCureVac N.V.4.45-160.44%
GLPGGalapagos NV4.86-166.06%
SRPTSarepta Therapeutics Inc4.88-166.38%
ABEOAbeona Therapeutics Inc5.39-173.25%
ABUSArbutus Biopharma Corp5.60-176.08%
ZVRAZevra Therapeutics Inc5.89-180.04%
SPROSpero Therapeutics Inc6.23-184.68%
CGENCompugen Ltd6.31-185.84%
RIGLRigel Pharmaceuticals6.87-193.43%
SLXNSilexion Therapeutics Corp7.30-199.20%
OMEROmeros Corporation9.26-225.88%
AUPHAurinia Pharmaceuticals Inc9.58-230.32%
PLXProtalix BioTherapeutics Inc10.89-248.07%
ACADAcadia Pharmaceuticals Inc11.73-259.46%
TBPHTheravance Biopharma Inc12.26-266.72%
ADMAAdma Biologics Inc12.42-268.84%
HRMYHarmony Biosciences Holdings Inc13.82-287.90%
SABSSAB Biotherapeutics Inc14.14-292.20%
NAGENiagen Bioscience Inc14.82-301.47%
INCYIncyte Corp15.82-315.12%
REGNRegeneron Pharmaceuticals Inc15.86-315.59%
PBYIPuma Biotechnology Inc17.32-335.42%
CPRXCatalyst Pharmaceuticals Inc17.44-337.10%
EXELExelixis Inc17.54-338.45%
TGTXTG Therapeutics Inc18.97-357.86%
MDXGMimedx Group Inc20.55-379.43%
XOMAXOMA Royalty Corp22.87-411.01%
ARGXArgen X SE24.30-430.36%
CTMXCytomX Therapeutics Inc24.82-437.48%
XOMAOXOMA Royalty Corp25.34-444.60%
HALOHalozyme Therapeutics Inc25.62-448.39%
XOMAPXOMA Royalty Corp25.67-449.02%
VRTXVertex Pharmaceuticals Inc27.99-480.63%
RPRXRoyalty Pharma plc - Class A28.69-490.05%
SLNOSoleno Therapeutics Inc29.02-494.50%
ASNDAscendis Pharma A/S30.09-509.05%
LGNDLigand Pharmaceuticals Inc - Class B37.91-615.47%
APLSApellis Pharmaceuticals Inc39.02-630.55%
BMRNBiomarin Pharmaceutical Inc42.21-673.93%
KRYSKrystal Biotech Inc45.34-716.51%
ONCBeiGene Ltd69.54-1045.50%
PHARPharming Group N.V.75.03-1120.07%
TECHBio-Techne Corp101.96-1486.26%
VCELVericel Corp109.92-1594.53%
ALNYAlnylam Pharmaceuticals Inc117.96-1703.90%
GMABGenmab140.29-2007.44%
TLXTelix Pharmaceuticals Ltd162.15-2304.69%
CORTCorcept Therapeutics Inc212.86-2994.09%